25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CATALYST PHARMA (CN2.SG)
Buy, Hold or Sell?

Let's analyze CATALYST PHARMA (CN2.SG) together

I guess you are interested in CATALYST PHARMA (CN2.SG). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CATALYST PHARMA (CN2.SG). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CATALYST PHARMA (CN2.SG)

I send you an email if I find something interesting about CATALYST PHARMA (CN2.SG).

1. Quick Overview

1.1. Quick analysis of CATALYST PHARMA (CN2.SG) (30 sec.)










1.2. What can you expect buying and holding a share of CATALYST PHARMA (CN2.SG)? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€5.51
Expected worth in 1 year
€7.71
How sure are you?
95.2%

+ What do you gain per year?

Total Gains per Share
€2.20
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
€19.59
Expected price per share
€17.25 - €22.06
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of CATALYST PHARMA (CN2.SG) (5 min.)




Live pricePrice per Share (EOD)
€19.59
Intrinsic Value Per Share
€25.55 - €30.29
Total Value Per Share
€31.06 - €35.80

2.2. Growth of CATALYST PHARMA (CN2.SG) (5 min.)




Is CATALYST PHARMA (CN2.SG) growing?

Current yearPrevious yearGrowGrow %
How rich?$727.6m$361.3m$278.3m43.5%

How much money is CATALYST PHARMA (CN2.SG) making?

Current yearPrevious yearGrowGrow %
Making money$40.9m$17.8m$23.1m56.4%
Net Profit Margin32.6%18.5%--

How much money comes from the company's main activities?

2.3. Financial Health of CATALYST PHARMA (CN2.SG) (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of CATALYST PHARMA (CN2.SG)?

Welcome investor! CATALYST PHARMA (CN2.SG)'s management wants to use your money to grow the business. In return you get a share of CATALYST PHARMA (CN2.SG).

First you should know what it really means to hold a share of CATALYST PHARMA (CN2.SG). And how you can make/lose money.

Speculation

The Price per Share of CATALYST PHARMA (CN2.SG) is €19.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of CATALYST PHARMA (CN2.SG).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in CATALYST PHARMA (CN2.SG), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €5.51. Based on the TTM, the Book Value Change Per Share is €0.55 per quarter. Based on the YOY, the Book Value Change Per Share is €0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of CATALYST PHARMA (CN2.SG).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.462.4%0.341.8%0.170.9%0.201.0%0.170.9%
Usd Book Value Change Per Share0.482.4%0.603.1%0.191.0%0.261.3%0.291.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.482.4%0.603.1%0.191.0%0.261.3%0.291.5%
Usd Price Per Share22.03-18.19-14.83-10.75-9.11-
Price to Earnings Ratio11.90-14.17-6.74-11.43-10.02-
Price-to-Total Gains Ratio46.11-36.97-23.24-39.86-38.17-
Price to Book Ratio3.66-3.38-4.38-3.64-3.21-
Price-to-Total Gains Ratio46.11-36.97-23.24-39.86-38.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share21.382903
Number of shares46
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.600.26
Usd Total Gains Per Share0.600.26
Gains per Quarter (46 shares)27.5911.90
Gains per Year (46 shares)110.3447.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011010004838
2022121009586
303313200143134
404414300190182
505525400238230
606626500286278
707727600333326
808838700381374
909939800428422
100110310900476470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CATALYST PHARMA (CN2.SG) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4380.549-20%0.176+149%0.237+85%0.263+67%
Book Value Per Share--5.5144.913+12%3.106+78%2.639+109%2.232+147%
Current Ratio--5.1685.126+1%3.576+45%6.710-23%6.460-20%
Debt To Asset Ratio--0.1450.140+4%0.167-13%0.139+4%0.148-2%
Debt To Equity Ratio--0.1700.163+5%0.200-15%0.163+4%0.176-3%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--2325958653.8201892389226.140+23%1380505792.027+68%1032034217.604+125%998156900.698+133%
Eps--0.4240.314+35%0.154+176%0.181+134%0.154+176%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--4.4764.213+6%3.828+17%4.011+12%3.958+13%
Free Cash Flow Per Share--0.5360.459+17%0.133+305%0.216+149%0.216+149%
Free Cash Flow To Equity Per Share--0.5700.732-22%0.109+422%0.263+117%0.263+117%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--30.290--------
Intrinsic Value_10Y_min--25.551--------
Intrinsic Value_1Y_max--1.407--------
Intrinsic Value_1Y_min--1.381--------
Intrinsic Value_3Y_max--5.468--------
Intrinsic Value_3Y_min--5.195--------
Intrinsic Value_5Y_max--11.026--------
Intrinsic Value_5Y_min--10.127--------
Market Cap--2439340217.8201988069319.140+23%1446701448.027+69%1081123964.965+126%915239893.702+167%
Net Profit Margin--0.3940.326+21%0.185+113%0.362+9%0.344+15%
Operating Margin----0%-0%0.071-100%0.102-100%
Operating Ratio--0.7090.750-5%0.904-22%0.784-10%0.802-11%
Pb Ratio3.552-3%3.6603.379+8%4.382-16%3.636+1%3.208+14%
Pe Ratio11.551-3%11.90214.166-16%6.741+77%11.428+4%10.015+19%
Price Per Share19.585-3%20.18016.661+21%13.579+49%9.845+105%8.343+142%
Price To Free Cash Flow Ratio9.128-3%9.4059.869-5%11.864-21%11.714-20%9.762-4%
Price To Total Gains Ratio44.750-3%46.10936.974+25%23.240+98%39.862+16%38.168+21%
Quick Ratio--0.5430.619-12%0.735-26%0.783-31%1.070-49%
Return On Assets--0.0660.054+22%0.039+67%0.065+1%0.068-4%
Return On Equity--0.0770.063+22%0.048+61%0.075+2%0.080-4%
Total Gains Per Share--0.4380.549-20%0.176+149%0.237+85%0.263+67%
Usd Book Value--727696613.722639716801.808+14%361378087.525+101%317327608.840+129%276110280.624+164%
Usd Book Value Change Per Share--0.4780.600-20%0.192+149%0.259+85%0.287+67%
Usd Book Value Per Share--6.0205.364+12%3.391+78%2.881+109%2.437+147%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--2539481658.2412066110557.100+23%1507236223.735+68%1126774958.780+125%1089787704.182+133%
Usd Eps--0.4630.343+35%0.168+176%0.197+134%0.168+176%
Usd Free Cash Flow--70795286.06359818311.394+18%15465373.203+358%26077338.762+171%21731115.635+226%
Usd Free Cash Flow Per Share--0.5860.501+17%0.145+305%0.235+149%0.235+149%
Usd Free Cash Flow To Equity Per Share--0.6220.799-22%0.119+422%0.287+117%0.287+117%
Usd Market Cap--2663271649.8162170574082.637+23%1579508640.956+69%1180371144.948+126%999258915.944+167%
Usd Price Per Share21.383-3%22.03318.191+21%14.825+49%10.749+105%9.108+142%
Usd Profit--55940967.11740975888.336+37%17854085.302+213%21644071.823+158%19364983.500+189%
Usd Revenue--141832593.616122944416.495+15%99559840.129+42%68208396.518+108%61103473.007+132%
Usd Total Gains Per Share--0.4780.600-20%0.192+149%0.259+85%0.287+67%
 EOD+4 -2MRQTTM+24 -11YOY+32 -35Y+28 -810Y+28 -8

3.3 Fundamental Score

Let's check the fundamental score of CATALYST PHARMA (CN2.SG) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.551
Price to Book Ratio (EOD)Between0-13.552
Net Profit Margin (MRQ)Greater than00.394
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.543
Current Ratio (MRQ)Greater than15.168
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.170
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.066
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of CATALYST PHARMA (CN2.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.032
Ma 20Greater thanMa 5020.671
Ma 50Greater thanMa 10021.270
Ma 100Greater thanMa 20020.879
OpenGreater thanClose18.810
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About CATALYST PHARMA (CN2.SG)

  • Other
  • 0

There is no Profile data available for CN2.SG.

Fundamental data was last updated by Penke on 2025-03-11 20:20:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit CATALYST PHARMA (CN2.SG) earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • A Net Profit Margin of 39.4% means that €0.39 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 39.4%. The company is making a huge profit. +2
  • The TTM is 32.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ39.4%TTM32.6%+6.8%
TTM32.6%YOY18.5%+14.1%
TTM32.6%5Y36.2%-3.5%
5Y36.2%10Y34.4%+1.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ39.4%5.6%+33.8%
TTM32.6%5.9%+26.7%
YOY18.5%6.1%+12.4%
5Y36.2%6.2%+30.0%
10Y34.4%6.1%+28.3%
4.3.1.2. Return on Assets

Shows how efficient CATALYST PHARMA (CN2.SG) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • 6.6% Return on Assets means that CATALYST PHARMA (CN2.SG) generated €0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 6.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.6%TTM5.4%+1.2%
TTM5.4%YOY3.9%+1.5%
TTM5.4%5Y6.5%-1.1%
5Y6.5%10Y6.8%-0.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%1.3%+5.3%
TTM5.4%1.2%+4.2%
YOY3.9%1.3%+2.6%
5Y6.5%1.3%+5.2%
10Y6.8%1.3%+5.5%
4.3.1.3. Return on Equity

Shows how efficient CATALYST PHARMA (CN2.SG) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • 7.7% Return on Equity means CATALYST PHARMA (CN2.SG) generated €0.08 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM6.3%+1.4%
TTM6.3%YOY4.8%+1.5%
TTM6.3%5Y7.5%-1.2%
5Y7.5%10Y8.0%-0.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%3.7%+4.0%
TTM6.3%3.4%+2.9%
YOY4.8%3.9%+0.9%
5Y7.5%3.9%+3.6%
10Y8.0%3.8%+4.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CATALYST PHARMA (CN2.SG).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient CATALYST PHARMA (CN2.SG) is operating .

  • Measures how much profit CATALYST PHARMA (CN2.SG) makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y7.1%-7.1%
5Y7.1%10Y10.2%-3.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-12.7%
TTM-8.2%-8.2%
YOY-7.8%-7.8%
5Y7.1%4.4%+2.7%
10Y10.2%6.8%+3.4%
4.3.2.2. Operating Ratio

Measures how efficient CATALYST PHARMA (CN2.SG) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are €0.71 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 0.709. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.750. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.709TTM0.750-0.040
TTM0.750YOY0.904-0.155
TTM0.7505Y0.784-0.034
5Y0.78410Y0.802-0.018
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7091.313-0.604
TTM0.7501.355-0.605
YOY0.9041.375-0.471
5Y0.7841.324-0.540
10Y0.8021.381-0.579
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CATALYST PHARMA (CN2.SG).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if CATALYST PHARMA (CN2.SG) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 5.17 means the company has €5.17 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 5.168. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.126. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.168TTM5.126+0.041
TTM5.126YOY3.576+1.551
TTM5.1265Y6.710-1.584
5Y6.71010Y6.460+0.251
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1681.426+3.742
TTM5.1261.416+3.710
YOY3.5761.538+2.038
5Y6.7101.562+5.148
10Y6.4601.496+4.964
4.4.3.2. Quick Ratio

Measures if CATALYST PHARMA (CN2.SG) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • A Quick Ratio of 0.54 means the company can pay off €0.54 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 0.543. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.619. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.619-0.076
TTM0.619YOY0.735-0.116
TTM0.6195Y0.783-0.165
5Y0.78310Y1.070-0.287
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5430.533+0.010
TTM0.6190.553+0.066
YOY0.7350.601+0.134
5Y0.7830.606+0.177
10Y1.0700.609+0.461
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CATALYST PHARMA (CN2.SG).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of CATALYST PHARMA (CN2.SG) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare CATALYST PHARMA (CN2.SG) to Other industry mean.
  • A Debt to Asset Ratio of 0.15 means that CATALYST PHARMA (CN2.SG) assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.140. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.140+0.006
TTM0.140YOY0.167-0.027
TTM0.1405Y0.139+0.001
5Y0.13910Y0.148-0.009
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.520-0.375
TTM0.1400.529-0.389
YOY0.1670.523-0.356
5Y0.1390.555-0.416
10Y0.1480.564-0.416
4.5.4.2. Debt to Equity Ratio

Measures if CATALYST PHARMA (CN2.SG) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • A Debt to Equity ratio of 17.0% means that company has €0.17 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CATALYST PHARMA (CN2.SG):

  • The MRQ is 0.170. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.163. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.163+0.007
TTM0.163YOY0.200-0.038
TTM0.1635Y0.163-0.001
5Y0.16310Y0.176-0.012
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1701.095-0.925
TTM0.1631.128-0.965
YOY0.2001.155-0.955
5Y0.1631.338-1.175
10Y0.1761.429-1.253
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings CATALYST PHARMA (CN2.SG) generates.

  • Above 15 is considered overpriced but always compare CATALYST PHARMA (CN2.SG) to the Other industry mean.
  • A PE ratio of 11.90 means the investor is paying €11.90 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CATALYST PHARMA (CN2.SG):

  • The EOD is 11.551. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.902. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.166. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.551MRQ11.902-0.351
MRQ11.902TTM14.166-2.264
TTM14.166YOY6.741+7.424
TTM14.1665Y11.428+2.738
5Y11.42810Y10.015+1.412
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD11.55114.397-2.846
MRQ11.90213.597-1.695
TTM14.16612.500+1.666
YOY6.74111.129-4.388
5Y11.42812.976-1.548
10Y10.01513.175-3.160
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CATALYST PHARMA (CN2.SG):

  • The EOD is 9.128. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.405. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.869. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.128MRQ9.405-0.277
MRQ9.405TTM9.869-0.464
TTM9.869YOY11.864-1.995
TTM9.8695Y11.714-1.845
5Y11.71410Y9.762+1.952
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD9.1289.234-0.106
MRQ9.4058.286+1.119
TTM9.8697.139+2.730
YOY11.8645.896+5.968
5Y11.7143.220+8.494
10Y9.7623.714+6.048
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of CATALYST PHARMA (CN2.SG) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 3.66 means the investor is paying €3.66 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of CATALYST PHARMA (CN2.SG):

  • The EOD is 3.552. Based on the equity, the company is fair priced.
  • The MRQ is 3.660. Based on the equity, the company is fair priced.
  • The TTM is 3.379. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.552MRQ3.660-0.108
MRQ3.660TTM3.379+0.281
TTM3.379YOY4.382-1.003
TTM3.3795Y3.636-0.257
5Y3.63610Y3.208+0.428
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.5521.575+1.977
MRQ3.6601.404+2.256
TTM3.3791.428+1.951
YOY4.3821.405+2.977
5Y3.6361.718+1.918
10Y3.2081.715+1.493
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets851,411
Total Liabilities123,779
Total Stockholder Equity727,632
 As reported
Total Liabilities 123,779
Total Stockholder Equity+ 727,632
Total Assets = 851,411

Assets

Total Assets851,411
Total Current Assets623,609
Long-term Assets227,802
Total Current Assets
Cash And Cash Equivalents 517,553
Net Receivables 65,476
Inventory 19,541
Other Current Assets 1,030
Total Current Assets  (as reported)623,609
Total Current Assets  (calculated)603,600
+/- 20,009
Long-term Assets
Property Plant Equipment 3,584
Long Term Investments 21,564
Intangible Assets 156,672
Long-term Assets  (as reported)227,802
Long-term Assets  (calculated)181,820
+/- 45,982

Liabilities & Shareholders' Equity

Total Current Liabilities120,678
Long-term Liabilities3,101
Total Stockholder Equity727,632
Total Current Liabilities
Accounts payable 16,593
Other Current Liabilities 417
Total Current Liabilities  (as reported)120,678
Total Current Liabilities  (calculated)17,010
+/- 103,668
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,188
Long-term Liabilities  (as reported)3,101
Long-term Liabilities  (calculated)3,188
+/- 87
Total Stockholder Equity
Retained Earnings 285,161
Total Stockholder Equity (as reported)727,632
Total Stockholder Equity (calculated)285,161
+/- 442,471
Other
Capital Stock121
Common Stock Shares Outstanding 120,879
Net Invested Capital 727,632
Net Working Capital 502,931
Property Plant and Equipment Gross 4,704



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
61,077
78,234
96,691
112,376
117,880
131,412
174,860
192,354
197,216
209,130
223,248
237,788
246,972
267,309
333,114
375,630
407,227
443,896
413,211
470,114
646,676
706,360
772,010
851,411
851,411772,010706,360646,676470,114413,211443,896407,227375,630333,114267,309246,972237,788223,248209,130197,216192,354174,860131,412117,880112,37696,69178,23461,077
   > Total Current Assets 
54,862
72,056
90,579
111,364
116,944
131,164
143,342
159,244
161,533
176,305
192,795
210,106
221,191
242,558
276,310
320,806
198,911
240,968
192,017
219,329
404,602
474,429
538,998
623,609
623,609538,998474,429404,602219,329192,017240,968198,911320,806276,310242,558221,191210,106192,795176,305161,533159,244143,342131,164116,944111,36490,57972,05654,862
       Cash And Cash Equivalents 
19,082
23,418
44,983
89,512
101,751
115,052
117,106
130,237
127,328
135,295
154,836
171,445
178,372
210,912
256,065
298,395
148,247
178,787
120,971
137,636
310,411
375,693
442,331
517,553
517,553442,331375,693310,411137,636120,971178,787148,247298,395256,065210,912178,372171,445154,836135,295127,328130,237117,106115,052101,75189,51244,98323,41819,082
       Short-term Investments 
26,551
36,503
31,562
5,007
0
0
10,003
10,041
15,971
19,980
19,956
19,821
19,424
9,876
0
0
0
0
0
0
0
0
0
0
00000000009,87619,42419,82119,95619,98015,97110,04110,003005,00731,56236,50326,551
       Net Receivables 
7,251
10,376
10,095
10,537
6,919
6,762
5,872
5,987
5,601
6,292
6,625
6,619
10,552
9,587
9,337
10,439
33,402
42,796
48,049
53,514
60,493
57,172
58,266
65,476
65,47658,26657,17260,49353,51448,04942,79633,40210,4399,3379,58710,5526,6196,6256,2925,6015,9875,8726,7626,91910,53710,09510,3767,251
       Inventory 
97
270
600
1,957
2,211
1,828
4,748
4,651
4,390
7,097
6,950
7,870
7,827
7,850
7,132
6,805
10,328
10,751
9,035
15,644
19,953
18,014
20,017
19,541
19,54120,01718,01419,95315,6449,03510,75110,3286,8057,1327,8507,8277,8706,9507,0974,3904,6514,7481,8282,2111,95760027097
       Other Current Assets 
306
382
431
517
327
292
590
529
276
321
228
327
433
394
466
354
548
361
352
351
143
1,030
509
1,030
1,0305091,030143351352361548354466394433327228321276529590292327517431382306
   > Long-term Assets 
6,215
6,178
6,111
1,013
936
248
31,518
33,110
35,683
32,825
30,453
27,682
25,781
24,751
56,804
54,824
208,316
202,928
221,194
250,785
242,074
231,931
233,012
227,802
227,802233,012231,931242,074250,785221,194202,928208,31654,82456,80424,75125,78127,68230,45332,82535,68333,11031,5182489361,0136,1116,1786,215
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,715
3,617
3,991
3,844
3,761
3,703
3,748
3,598
3,681
3,584
3,5843,6813,5983,7483,7033,7613,8443,9913,6173,71500000000000000
       Long Term Investments 
4,992
5,008
5,009
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,897
16,489
15,345
13,083
14,842
21,564
21,56414,84213,08315,34516,48912,8970000000000000005,0095,0084,992
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,051
32,471
184,083
175,595
167,108
194,049
184,705
175,361
166,016
156,672
156,672166,016175,361184,705194,049167,108175,595184,08332,47133,05100000000000000
       Long-term Assets Other 
1,074
6,178
6,111
1,013
936
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000009361,0136,1116,1781,074
> Total Liabilities 
9,901
14,953
18,708
24,746
18,204
20,210
18,232
22,756
18,565
20,186
24,587
30,957
26,751
26,217
63,073
75,209
73,566
68,602
64,663
82,233
85,264
97,705
111,069
123,779
123,779111,06997,70585,26482,23364,66368,60273,56675,20963,07326,21726,75130,95724,58720,18618,56522,75618,23220,21018,20424,74618,70814,9539,901
   > Total Current Liabilities 
9,026
14,152
17,982
24,099
17,636
20,210
18,232
22,756
14,436
16,135
20,614
27,063
22,938
22,488
44,681
57,588
56,709
52,503
57,806
76,063
79,566
92,318
105,395
120,678
120,678105,39592,31879,56676,06357,80652,50356,70957,58844,68122,48822,93827,06320,61416,13514,43622,75618,23220,21017,63624,09917,98214,1529,026
       Accounts payable 
2,940
3,329
4,147
4,117
1,348
5,805
2,005
4,256
2,561
2,924
2,752
2,768
5,139
2,315
2,529
3,975
3,391
4,421
4,598
14,795
10,261
7,116
11,563
16,593
16,59311,5637,11610,26114,7954,5984,4213,3913,9752,5292,3155,1392,7682,7522,9242,5614,2562,0055,8051,3484,1174,1473,3292,940
       Other Current Liabilities 
166
153
531
172
140
31
70
107
111
112
110
243
141
230
237
238
279
455
374
465
631
372
449
417
4174493726314653744552792382372301412431101121111077031140172531153166
   > Long-term Liabilities 
875
801
726
648
568
0
0
0
4,129
4,051
3,973
3,894
3,813
3,729
18,392
17,621
16,857
16,099
6,857
6,170
5,698
5,387
5,674
3,101
3,1015,6745,3875,6986,1706,85716,09916,85717,62118,3923,7293,8133,8943,9734,0514,129000568648726801875
       Capital Lease Obligations Min Short Term Debt
1,158
1,090
1,020
948
875
198
115
29
4,251
4,251
4,251
4,202
4,129
4,051
3,973
3,894
3,813
3,729
3,643
3,557
3,468
3,376
3,282
3,188
3,1883,2823,3763,4683,5573,6433,7293,8133,8943,9734,0514,1294,2024,2514,2514,251291151988759481,0201,0901,158
> Total Stockholder Equity
51,176
63,282
77,983
87,630
99,676
111,201
156,628
169,598
178,651
188,944
198,661
206,831
220,221
241,092
270,041
300,421
333,661
375,294
348,548
387,881
561,412
608,655
660,941
727,632
727,632660,941608,655561,412387,881348,548375,294333,661300,421270,041241,092220,221206,831198,661188,944178,651169,598156,628111,20199,67687,63077,98363,28251,176
   Common Stock000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue491,734
Cost of Revenue-68,845
Gross Profit422,889422,889
 
Operating Income (+$)
Gross Profit422,889
Operating Expense-296,610
Operating Income195,124126,279
 
Operating Expense (+$)
Research Development12,648
Selling General Administrative177,740
Selling And Marketing Expenses-
Operating Expense296,610190,388
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-16,064
Net Interest Income16,064
 
Pretax Income (+$)
Operating Income195,124
Net Interest Income16,064
Other Non-Operating Income Expenses-
Income Before Tax (EBT)216,263190,049
EBIT - interestExpense = 0
163,889
163,889
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-216,263
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax216,263
Tax Provision-52,374
Net Income From Continuing Ops163,889163,889
Net Income163,889
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net5,075-16,064
 

Technical Analysis of CATALYST PHARMA (CN2.SG)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of CATALYST PHARMA (CN2.SG). The general trend of CATALYST PHARMA (CN2.SG) is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine CATALYST PHARMA (CN2.SG)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CATALYST PHARMA (CN2.SG).

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 19.41 < 21.47 < 22.06.

The bearish price targets are: 19.05 > 18.61 > 17.25.

Tweet this
CATALYST PHARMA (CN2.SG) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CATALYST PHARMA (CN2.SG). The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CATALYST PHARMA (CN2.SG) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CATALYST PHARMA (CN2.SG). The current macd is -0.54056217.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the CATALYST PHARMA (CN2.SG) price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for CATALYST PHARMA (CN2.SG). This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the CATALYST PHARMA (CN2.SG) price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CATALYST PHARMA (CN2.SG) Daily Moving Average Convergence/Divergence (MACD) ChartCATALYST PHARMA (CN2.SG) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CATALYST PHARMA (CN2.SG). The current adx is 15.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell CATALYST PHARMA (CN2.SG) shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
CATALYST PHARMA (CN2.SG) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CATALYST PHARMA (CN2.SG). The current sar is 20.43.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CATALYST PHARMA (CN2.SG) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CATALYST PHARMA (CN2.SG). The current rsi is 42.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CATALYST PHARMA (CN2.SG) Daily Relative Strength Index (RSI) ChartCATALYST PHARMA (CN2.SG) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CATALYST PHARMA (CN2.SG). The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the CATALYST PHARMA (CN2.SG) price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CATALYST PHARMA (CN2.SG) Daily Stochastic Oscillator ChartCATALYST PHARMA (CN2.SG) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CATALYST PHARMA (CN2.SG). The current cci is -105.16693929.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CATALYST PHARMA (CN2.SG) Daily Commodity Channel Index (CCI) ChartCATALYST PHARMA (CN2.SG) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CATALYST PHARMA (CN2.SG). The current cmo is -18.30153348.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CATALYST PHARMA (CN2.SG) Daily Chande Momentum Oscillator (CMO) ChartCATALYST PHARMA (CN2.SG) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CATALYST PHARMA (CN2.SG). The current willr is -71.63531114.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that CATALYST PHARMA (CN2.SG) is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CATALYST PHARMA (CN2.SG) Daily Williams %R ChartCATALYST PHARMA (CN2.SG) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CATALYST PHARMA (CN2.SG).

CATALYST PHARMA (CN2.SG) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CATALYST PHARMA (CN2.SG). The current atr is 0.68425388.

CATALYST PHARMA (CN2.SG) Daily Average True Range (ATR) ChartCATALYST PHARMA (CN2.SG) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CATALYST PHARMA (CN2.SG). The current obv is 78.00.

CATALYST PHARMA (CN2.SG) Daily On-Balance Volume (OBV) ChartCATALYST PHARMA (CN2.SG) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CATALYST PHARMA (CN2.SG). The current mfi is 15.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
CATALYST PHARMA (CN2.SG) Daily Money Flow Index (MFI) ChartCATALYST PHARMA (CN2.SG) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CATALYST PHARMA (CN2.SG).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

CATALYST PHARMA (CN2.SG) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CATALYST PHARMA (CN2.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.032
Ma 20Greater thanMa 5020.671
Ma 50Greater thanMa 10021.270
Ma 100Greater thanMa 20020.879
OpenGreater thanClose18.810
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of CATALYST PHARMA (CN2.SG) with someone you think should read this too:
  • Are you bullish or bearish on CATALYST PHARMA (CN2.SG)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about CATALYST PHARMA (CN2.SG)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CATALYST PHARMA (CN2.SG)

I send you an email if I find something interesting about CATALYST PHARMA (CN2.SG).


Comments

How you think about this?

Leave a comment

Stay informed about CATALYST PHARMA (CN2.SG).

Receive notifications about CATALYST PHARMA (CN2.SG) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.